Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale President, COO & GM China sold 1,459 shares at an average $159.79 ($233,133)
  2. 4 Open-market sale Chief Executive Officer sold 2,789 shares at an average $159.58 ($445,070)
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 4 Open-market sale Chief Executive Officer sold 1,281 shares at an average $159.35 ($204,125)
  8. 4 Open-market sale Chief Financial Officer sold 916 shares at an average $159.04 ($145,678)
  9. 4 Open-market sale Global Head of R&D sold 2,341 shares at an average $157.27 ($368,162)
  10. 4 Open-market sale President, COO & GM China sold 3,254 shares at an average $155.26 ($505,208)
  11. 4 Open-market sale SVP, General Counsel sold 439 shares at an average $159.35 ($69,955)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 4 Grant or award Principal Accounting Officer acquired 24,427 shares (grant or award)
  20. 4 Grant or award President, COO & GM China acquired 253,409 shares (grant or award)

Page 20 of 64 · 1,278 filings